The Business Of Autism Treatment: Private Equity Implications For State Medicaid Programs Yashaswini Singh,Corrie Mook,Jared Perkins,Nathan Hostert,andDaniel R. Arnold May 22, 2026

https://www.healthaffairs.org/content/forefront/business-autism-treatment-private-equity-implications-state-medicaid-programs?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-9TrR4WFLDHZVr1KMLUOJhc8iK6O2-MHvgWzs7cy1F1KYjW92FOMAgBMKH9u2Op-EZ6mDvizhGUDoQcp2iKqeUVFoPC3A&_hsmi=420157662&utm_source=hasu The rapid expansion of autism therapy for children has been driven by increased need, generous taxpayer-funded Medicaid payments, and private equity penetration. Some companies have capitalized on the opportunity, at times outpacing regulatory oversight.